Dear Sir/Madam, Please find the attached outcome of Extraordinary General Meeting held on Friday, the 20th Day of March, 2026 at 01:00 P.M. through Video Conferencing/OAVM. Thanks.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Prism Medico and Pharmacy Ltd held an Extraordinary General Meeting on March 20, 2026, via video conferencing, which concluded in just 17 minutes. Two special businesses were approved: (1) alteration of Clause 15 of the Articles of Association, and (2) issue of equity shares and convertible warrants on a preferential basis. The company is listed on BSE (Scrip Code: 512217) and MSEI. The quick conclusion suggests shareholders voted in favour of both resolutions without extended deliberation.
Shareholders have approved a preferential issue of equity shares and convertible warrants, which signals potential equity dilution but also indicates the company may be raising capital. The AOA amendment could be related to enabling this issuance. Existing shareholders should watch for further details on the preferential allotment pricing, quantity, and allottees, as these will determine the actual dilution impact.